Gland Pharma shares tank 19%, hit 52-week low as Q4 earning weighs

Gland Pharma shares reached a 52-week low of Rs 861 on May 24th, falling for the fifth consecutive day. The fall comes after the company reported a 56% decline in Q4 earnings on May 18th. Adding to its challenges, its EBITDA margin contracted to 21%, while revenue fell 29% YoY to INR7.85bn; weak sales in both the domestic and international markets contributed to the drop. The Hyderabad-based company, which relies on a B2B model, is also dealing with the production line shutdown in Hyderabad.